{"id":30689,"date":"2014-09-09T09:43:48","date_gmt":"2014-09-09T13:43:48","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=30689"},"modified":"2014-09-09T09:43:48","modified_gmt":"2014-09-09T13:43:48","slug":"merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689","title":{"rendered":"Merck &#038; Co., Inc. (NYSE:MRK) Sued For Using Patented Method In Developing Cancer Drug \u2018Keytruda\u2019"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 09\/09\/2014 (wallstreetpr)<strong>\u00a0\u2013\u00a0Bristol-Myers Squibb Co (NYSE:BMY),<\/strong> along with its partner <strong>ONO PHARMACEUTICAL CO., LTD.,<\/strong> sued <strong>Merck &amp; Co., Inc. (NYSE:MRK)<\/strong> for patent infringement.<\/p>\n<p style=\"text-align: justify;\">The matter concerns Merck\u2019s newly launched drug, \u2018Keytruda,\u2019 which is aimed at treating the deadly skin cancer melanoma. As the drug received approval from the U.S. Food and Drug Administration on Thursday, immediate action was taken by \u00a0Bristol-Myers Squibb Co (NYSE:BMY)\u00a0and Ono and the two approached the federal court in Delaware on the same day itself. They filed a lawsuit against Merck, claiming that its new drug violates a patent for a process of spurring the body\u2019s immune system to combat cancer.<\/p>\n<p style=\"text-align: justify;\"><strong>Competition In Emerging Market<\/strong><\/p>\n<p style=\"text-align: justify;\">As reported by the Wall Street journal in an <a href=\"http:\/\/online.wsj.com\/articles\/bristol-myers-ono-suing-merck-over-cancer-drug-patent-1410101449?ru=yahoo?mod=yahoo_itp\">article<\/a>, the argument underlines the multicompany competition in the emerging market for cancer drugs targeting the immune response of the body. Some analysts believe that the annual sales in this market could surge up to as high as $30 billion in a short span of only about ten years. Immunotherapy drugs have showed promising results particularly in the treatment of melanoma, although significant outcome have also been achieved for other cancers as well.<\/p>\n<p style=\"text-align: justify;\"><strong>Patent Infringement<\/strong><\/p>\n<p style=\"text-align: justify;\">The present dispute on \u2018Keytruda,\u2019 whose generic name is pembrolizumab, concerns the method by which the drug functions. It essentially blocks a part of programmed death receptor 1 (PD-1), specific cells of the immune system. The process allows the immune system to brake off, resulting in hence an enhanced ability to obliterate malignant cells. The side effects, in this treatment method, are also manageable, according to doctors.<\/p>\n<p style=\"text-align: justify;\">Bristol-Myers Squibb Co (NYSE:BMY) and Ono have also been working on a drug, nivolumab, which works on the same principle of blocking PD-1. The companies are already selling the drug as melanoma therapy in Japan since last week, under brand name Opdivo. Bristol-Myers reported that it expected to file for FDA approval of the drug on Sept 30 and commence marketing the drug as a treatment for lung cancer. The company claims to have obtained exclusive rights toONO PHARMACEUTICAL CO., LTD.\u2019s patents on the new method for treating cancer.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 09\/09\/2014 (wallstreetpr)\u00a0\u2013\u00a0Bristol-Myers Squibb Co (NYSE:BMY), along with its partner ONO PHARMACEUTICAL CO., LTD., sued Merck &amp; Co., Inc. (NYSE:MRK) for patent infringement. The [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":19777,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[3685,670,1683,997,1123,8867],"stock_ticker":[],"class_list":["post-30689","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-bristol-myers-squibb-co-nysebmy","tag-ltd","tag-merck-co-inc-nysemrk","tag-nysebmy","tag-nysemrk","tag-ono-pharmaceutical-co","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merck &amp; Co., Inc. (NYSE:MRK) Sued For Using Patented Method In Developing Cancer Drug \u2018Keytruda\u2019  - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck &amp; Co., Inc. (NYSE:MRK) Sued For Using Patented Method In Developing Cancer Drug \u2018Keytruda\u2019  - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 09\/09\/2014 (wallstreetpr)\u00a0\u2013\u00a0Bristol-Myers Squibb Co (NYSE:BMY), along with its partner ONO PHARMACEUTICAL CO., LTD., sued Merck &amp; Co., Inc. (NYSE:MRK) for patent infringement. The [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-09-09T13:43:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"275\" \/>\n\t<meta property=\"og:image:height\" content=\"183\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Merck &#038; Co., Inc. (NYSE:MRK) Sued For Using Patented Method In Developing Cancer Drug \u2018Keytruda\u2019\",\"datePublished\":\"2014-09-09T13:43:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689\"},\"wordCount\":371,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg\",\"keywords\":[\"Bristol-Myers Squibb Co (NYSE:BMY)\",\"LTD\",\"Merck &amp; Co Inc. (NYSE:MRK)\",\"NYSE:BMY\",\"NYSE:MRK\",\"ONO PHARMACEUTICAL CO.\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689\",\"name\":\"Merck & Co., Inc. (NYSE:MRK) Sued For Using Patented Method In Developing Cancer Drug \u2018Keytruda\u2019 - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg\",\"datePublished\":\"2014-09-09T13:43:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg\",\"width\":275,\"height\":183},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck &#038; Co., Inc. (NYSE:MRK) Sued For Using Patented Method In Developing Cancer Drug \u2018Keytruda\u2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merck & Co., Inc. (NYSE:MRK) Sued For Using Patented Method In Developing Cancer Drug \u2018Keytruda\u2019  - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689","og_locale":"en_US","og_type":"article","og_title":"Merck & Co., Inc. (NYSE:MRK) Sued For Using Patented Method In Developing Cancer Drug \u2018Keytruda\u2019  - Wall Street PR","og_description":"Boston, MA 09\/09\/2014 (wallstreetpr)\u00a0\u2013\u00a0Bristol-Myers Squibb Co (NYSE:BMY), along with its partner ONO PHARMACEUTICAL CO., LTD., sued Merck &amp; Co., Inc. (NYSE:MRK) for patent infringement. The [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-09-09T13:43:48+00:00","og_image":[{"width":275,"height":183,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Merck &#038; Co., Inc. (NYSE:MRK) Sued For Using Patented Method In Developing Cancer Drug \u2018Keytruda\u2019","datePublished":"2014-09-09T13:43:48+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689"},"wordCount":371,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg","keywords":["Bristol-Myers Squibb Co (NYSE:BMY)","LTD","Merck &amp; Co Inc. (NYSE:MRK)","NYSE:BMY","NYSE:MRK","ONO PHARMACEUTICAL CO."],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689","url":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689","name":"Merck & Co., Inc. (NYSE:MRK) Sued For Using Patented Method In Developing Cancer Drug \u2018Keytruda\u2019 - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg","datePublished":"2014-09-09T13:43:48+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg","width":275,"height":183},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-sued-for-using-patented-method-in-developing-cancer-drug-keytruda-30689#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Merck &#038; Co., Inc. (NYSE:MRK) Sued For Using Patented Method In Developing Cancer Drug \u2018Keytruda\u2019"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/30689","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=30689"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/30689\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/19777"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=30689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=30689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=30689"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=30689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}